{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:03:09Z","timestamp":1790161389195,"version":"4.1.0"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Septic shock remains a high-mortality syndrome despite advances in early recognition, antimicrobial therapy, source control, and protocolized resuscitation. A major limitation of current practice is that septic shock is often managed as a single clinical entity, whereas patients meeting the same diagnostic criteria may differ substantially in hemodynamic phenotype, endothelial injury, microcirculatory function, immune state, coagulation activation, fluid tolerance, and vasopressor responsiveness. These differences help explain why biologically plausible therapies frequently fail when tested in unselected populations. This narrative review synthesizes evidence supporting a precision-oriented approach to septic shock across three therapeutic domains\u2014fluid therapy, vasopressor support, and immunomodulation\u2014supported by two cross-cutting precision layers: biological phenotyping and bedside precision tools. We distinguish bedside clinical phenotypes from biological endotypes and explain how this framework can refine resuscitation decisions. Fluid therapy is reframed as a titrated intervention requiring assessment of both fluid responsiveness and fluid tolerance. Vasopressor therapy is discussed beyond a uniform mean arterial pressure target, with emphasis on timing, agent selection, tissue perfusion, and individualized weaning. Immune, endothelial, and coagulation phenotyping are presented as biological bridges between bedside physiology and targeted therapy, while immunomodulation is considered a promising but still investigational frontier requiring patient stratification. Finally, we propose a pragmatic precision-resuscitation framework that integrates lactate kinetics, capillary refill time, point-of-care ultrasound, congestion assessment, and immune\/endothelial biomarkers where available. Precision care should not delay time-critical sepsis interventions; rather, it should mature protocolized management into a dynamic process of early treatment, repeated reassessment, and phenotype-directed adjustment.<\/jats:p>","DOI":"10.3389\/fmed.2026.1909143","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:06:11Z","timestamp":1790157971000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Septic shock in the era of precision medicine: rethinking fluids, vasopressors, and immunomodulation"],"prefix":"10.3389","volume":"13","author":[{"given":"Jialiang","family":"Du","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Aerospace Center Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Emergency, Hangzho Geriatric Hospital","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyong","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Emergency, Hangzho Geriatric Hospital","place":["Hangzhou, Zhejiang, China"]},{"name":"Department of Emergency, Hangzhou First People\u2019s Hospital","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Emergency, Hangzho Geriatric Hospital","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Al-Danakh","sequence":"additional","affiliation":[{"name":"Amran Medical College, Amran University","place":["Amran, Yemen"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siding","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Emergency, Hangzho Geriatric Hospital","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock","volume":"315","author":"Shankar-Hari","year":"2016","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis And Septic Shock","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","article-title":"Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019: results from a systematic review and meta-analysis","volume":"24","author":"Bauer","year":"2020","journal-title":"Critical Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","article-title":"Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis","volume":"23","author":"Vincent","year":"2019","journal-title":"Critical Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/CCM.0000000000007075","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2026","volume":"54","author":"Prescott","year":"2026","journal-title":"Crit Care Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1056\/NEJMoa1701380","article-title":"Early, goal-directed therapy for septic shock: a patient-level meta-analysis","volume":"376","author":"Rowan","year":"2017","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1097\/CCM.0000000000006463","article-title":"Heterogeneity in the effect of early goal-directed therapy for septic shock: a secondary analysis of two multicenter international trials","volume":"53","author":"Shah","year":"2025","journal-title":"Crit Care Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s00134-025-07873-6","article-title":"Sepsis subphenotypes, theragnostics and personalized sepsis care","volume":"51","author":"Antcliffe","year":"2025","journal-title":"Intensive Care Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s43856-024-00542-7","article-title":"Sepsis endotypes identified by host gene expression across global cohorts","volume":"4","author":"Chenoweth","year":"2024","journal-title":"Communications Medicine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s00134-018-5175-z","article-title":"Surviving sepsis campaign: research priorities for sepsis and septic shock","volume":"44","author":"Coopersmith","year":"2018","journal-title":"Intensive Care Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1056\/NEJMoa2212663","article-title":"Early restrictive or liberal fluid management for sepsis-induced hypotension","volume":"388","author":"Shapiro","year":"2023","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.chest.2024.05.042","article-title":"Comparison of early and late norepinephrine administration in patients with septic shock: a systematic review and meta-analysis","volume":"166","author":"Ahn","year":"2024","journal-title":"Chest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s13054-023-04762-6","article-title":"Targeting the host response in sepsis: current approaches and future evidence","volume":"27","author":"Bode","year":"2023","journal-title":"Critical Care"},{"key":"B15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13054-024-04964-6","article-title":"Towards personalized medicine: a scoping review of immunotherapy in sepsis","volume":"28","author":"Slim","year":"2024","journal-title":"Critical Care"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.3390\/medicina60111740","article-title":"A multivariate phenotypical approach of sepsis and septic shock: a comprehensive narrative literature review","volume":"60","author":"Tita","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jcrc.2014.03.007","article-title":"Correlation of left ventricular systolic dysfunction determined by low ejection fraction and 30-day mortality in patients with severe sepsis and septic shock: a systematic review and meta-analysis","volume":"29","author":"Sevilla Berrios","year":"2014","journal-title":"J Crit Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13613-020-00767-4","article-title":"Effects of capillary refill time versus lactate-targeted fluid resuscitation on regional, microcirculatory and hypoxia-related perfusion parameters in septic shock: a randomized controlled trial","volume":"10","author":"Castro","year":"2020","journal-title":"Ann Intensive Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s13054-014-0503-3","article-title":"Sepsis-associated hyperlactatemia","volume":"18","author":"Garcia-Alvarez","year":"2014","journal-title":"Critical Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13017-019-0286-6","article-title":"Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis","volume":"15","author":"Nawijn","year":"2020","journal-title":"World J Emerg Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jinf.2016.01.010","article-title":"Defining immunological dysfunction in sepsis: a requisite tool for precision medicine","volume":"72","author":"Bermejo-Martin","year":"2016","journal-title":"J Infect"},{"key":"B22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13054-018-2292-6","article-title":"The glycocalyx: a novel diagnostic and therapeutic target in sepsis","volume":"23","author":"Uchimido","year":"2019","journal-title":"Critical Care"},{"key":"B23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13613-017-0325-y","article-title":"Endothelial glycocalyx degradation is more severe in patients with non-pulmonary sepsis compared with pulmonary sepsis and associates with risk of acute respiratory distress syndrome and other organ dysfunction","volume":"7","author":"Murphy","year":"2017","journal-title":"Ann Intensive Care"},{"key":"B24","doi-asserted-by":"publisher","first-page":"104683","DOI":"10.1016\/j.mvr.2024.104683","article-title":"Biomarkers of endothelial glycocalyx damage are associated with microvascular dysfunction in resuscitated septic shock patients","volume":"154","author":"Soubihe Neto","year":"2024","journal-title":"Microvasc Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e70155","DOI":"10.1002\/mbo3.70155","article-title":"Glycocalyx and endothelial biomarkers as prognostic indicators in sepsis: a systematic review and meta-analysis","volume":"14","author":"Daniyarova","year":"2025","journal-title":"MicrobiologyOpen"},{"key":"B26","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","article-title":"Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study","volume":"5","author":"Scicluna","year":"2017","journal-title":"Lancet Respiratory Medicine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s00134-023-07239-w","article-title":"Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes","volume":"49","author":"van Amstel","year":"2023","journal-title":"Intensive Care Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","article-title":"Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study","volume":"4","author":"Davenport","year":"2016","journal-title":"Lancet Respir Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1038\/s41591-025-03956-5","article-title":"A consensus immune dysregulation framework for sepsis and critical illnesses","volume":"31","author":"Moore","year":"2025","journal-title":"Nat Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.annemergmed.2018.03.039","article-title":"Liberal versus restrictive intravenous fluid therapy for early septic shock: rationale for a randomized trial","volume":"72","author":"Self","year":"2018","journal-title":"Ann Emerg Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1097\/CCM.0000000000004617","article-title":"Fluid overload and mortality in adult critical care patients: a systematic review and meta-analysis of observational studies","volume":"48","author":"Messmer","year":"2020","journal-title":"Crit Care Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.5114\/ait.2022.115368","article-title":"Methods of assessing fluid responsiveness in septic shock patients: a narrative review","volume":"54","author":"Weigl","year":"2022","journal-title":"Anaesthesiol Intensive Ther"},{"key":"B34","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/CCM.0000000000001556","article-title":"Predicting fluid responsiveness by passive leg raising: a systematic review and meta-analysis of 23 clinical trials","volume":"44","author":"Cherpanath","year":"2016","journal-title":"Crit Care Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1097\/CCM.0000000000002554","article-title":"Incorporating dynamic assessment of fluid responsiveness into goal-directed therapy: a systematic review and meta-analysis","volume":"45","author":"Bednarczyk","year":"2017","journal-title":"Crit Care Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.chest.2020.04.025","article-title":"Fluid response evaluation in sepsis hypotension and shock: a randomized clinical trial","volume":"158","author":"Douglas","year":"2020","journal-title":"Chest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1303","DOI":"10.1097\/CCE.0000000000001303","article-title":"Dynamic measures of fluid responsiveness to guide resuscitation in patients with sepsis and septic shock: a systematic review and meta-analysis","volume":"7","author":"Wang","year":"2025","journal-title":"Critical Care Explorations"},{"key":"B38","doi-asserted-by":"publisher","first-page":"154070","DOI":"10.1016\/j.jcrc.2022.154070","article-title":"The emerging concept of fluid tolerance: a position paper","volume":"71","author":"Kattan","year":"2022","journal-title":"J Crit Care"},{"key":"B39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13054-020-2732-y","article-title":"Systematic assessment of fluid responsiveness during early septic shock resuscitation: secondary analysis of the ANDROMEDA-SHOCK trial","volume":"24","author":"Kattan","year":"2020","journal-title":"Crit Care"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1056\/NEJMoa2202707","article-title":"Restriction of intravenous fluid in ICU patients with septic shock","volume":"386","author":"Meyhoff","year":"2022","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2516225","article-title":"Vasopressors or fluids in early septic shock","author":"Peake","year":"2026","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00134-016-4573-3","article-title":"Conservative fluid management or de-resuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis","volume":"43","author":"Silversides","year":"2017","journal-title":"Intensive Care Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejim.2023.01.009","article-title":"Active fluid de-resuscitation in critically ill patients with septic shock: a systematic review and meta-analysis","volume":"109","author":"Messmer","year":"2023","journal-title":"Eur J Intern Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","volume":"378","author":"Semler","year":"2018","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1164\/rccm.201903-0557OC","article-title":"Balanced crystalloids versus saline in sepsis: a secondary analysis of the SMART clinical trial","volume":"200","author":"Brown","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1001\/jama.2021.11684","article-title":"Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients: the BaSICS randomized clinical trial","volume":"326","author":"Zampieri","year":"2021","journal-title":"JAMA"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe sepsis or septic shock","volume":"370","author":"Caironi","year":"2014","journal-title":"N Engl J Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e2559297","DOI":"10.1001\/jamanetworkopen.2025.59297","article-title":"Albumin replacement therapy in septic shock: a randomized clinical trial","volume":"9","author":"Sakr","year":"2026","journal-title":"JAMA Netw. Open"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e2618973","DOI":"10.1001\/jamanetworkopen.2026.18973","article-title":"Error in methods","volume":"9","year":"2026","journal-title":"JAMA Netw Open"},{"key":"B50","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.42 versus ringer\u2019s acetate in severe sepsis","volume":"367","author":"Perner","year":"2012","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s13054-023-04739-5","article-title":"The alternative renin-angiotensin system in critically ill patients: pathophysiology and therapeutic implications","volume":"27","author":"Garcia","year":"2023","journal-title":"Critical Care"},{"key":"B52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13613-019-0511-1","article-title":"Narrative review: clinical assessment of peripheral tissue perfusion in septic shock","volume":"9","author":"Hariri","year":"2019","journal-title":"Ann Intensive Care"},{"key":"B53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13613-022-01053-1","article-title":"Effects of mean arterial pressure target on mottling and arterial lactate normalization in patients with septic shock: a post hoc analysis of the SEPSISPAM randomized trial","volume":"12","author":"Fage","year":"2022","journal-title":"Ann Intensive Care"},{"key":"B54","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1164\/rccm.201806-1034OC","article-title":"Early use of norepinephrine in septic shock resuscitation (CENSER): a randomized trial","volume":"199","author":"Permpikul","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13054-025-05400-z","article-title":"Early norepinephrine for patients with septic shock: an updated systematic review and meta-analysis with trial sequential analysis","volume":"29","author":"Shi","year":"2025","journal-title":"Critical Care"},{"key":"B57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s44158-024-00150-w","article-title":"Angiotensin II therapy in refractory septic shock: which patient can benefit most? A narrative review","volume":"4","author":"Coloretti","year":"2024","journal-title":"J Anesth Analg Crit Care"},{"key":"B58","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","article-title":"Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials","volume":"45","author":"Nagendran","year":"2019","journal-title":"Intensive Care Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock: a clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13063-024-07995-0","article-title":"The scientific rationale and study protocol for the DPP3, angiotensin II, and renin kinetics in sepsis randomized controlled trial","volume":"25","author":"Teixeira","year":"2024","journal-title":"Trials"},{"key":"B62","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s13054-024-05212-7","article-title":"Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials","volume":"28","author":"Kotani","year":"2024","journal-title":"Critical Care"},{"key":"B63","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13613-024-01304-3","article-title":"Renin in critically ill patients","volume":"14","author":"Kotani","year":"2024","journal-title":"Ann Intensive Care"},{"key":"B64","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/CCM.0000000000005143","article-title":"Renin kinetics are superior to lactate kinetics for predicting in-hospital mortality in hypotensive critically ill patients","volume":"50","author":"Jeyaraju","year":"2022","journal-title":"Crit Care Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3343\/alm.2023.0425","article-title":"Diagnostic accuracy of plasma renin concentration and renin activity in predicting mortality and kidney outcomes in patients with septic shock and hypoperfusion or hypotension: a multicenter, prospective, observational study","volume":"44","author":"Lee","year":"2024","journal-title":"Ann Lab Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N Engl J Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00134-025-07910-4","article-title":"Efficacy of targeting high mean arterial pressure for older patients with septic shock: the OPTPRESS randomized controlled trial","volume":"51","author":"Endo","year":"2025","journal-title":"Intensive Care Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2019.0071","article-title":"Effect of a resuscitation strategy targeting peripheral perfusion status versus serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial","volume":"321","author":"Hern\u00e1ndez","year":"2019","journal-title":"JAMA"},{"key":"B69","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/SHK.0000000000001345","article-title":"Norepinephrine vs vasopressin: which vasopressor should be discontinued first in septic shock? A meta-analysis","volume":"53","author":"Wu","year":"2020","journal-title":"Shock"},{"key":"B70","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/phar.2265","article-title":"Effects of norepinephrine and vasopressin discontinuation order in the recovery phase of septic shock: a systematic review and individual patient data meta-analysis","volume":"39","author":"Hammond","year":"2019","journal-title":"Pharmacotherapy"},{"key":"B71","doi-asserted-by":"publisher","first-page":"103776","DOI":"10.1016\/j.ebiom.2021.103776","article-title":"Predicting sepsis severity at first clinical presentation: the role of endotypes and mechanistic signatures","volume":"75","author":"Baghela","year":"2022","journal-title":"EBioMedicine"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.3390\/biomedicines13102386","article-title":"Immune dysregulation in sepsis: a narrative review for clinicians","volume":"13","author":"Valsamaki","year":"2025","journal-title":"Biomedicines"},{"key":"B73","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","article-title":"Transcriptomic signatures in sepsis and a differential response to steroids: from the VANISH randomized trial","volume":"199","author":"Antcliffe","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1164\/rccm.v206erratum10","article-title":"Erratum: transcriptomic signatures in sepsis and a differential response to steroids: from the VANISH randomized trial","volume":"206","author":"Antcliffe","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"100817","DOI":"10.1016\/j.xcrm.2022.100817","article-title":"Toward personalized immunotherapy in sepsis: the PROVIDE randomized clinical trial","volume":"3","author":"Leventogiannis","year":"2022","journal-title":"Cell Rep. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2025.24175","article-title":"Precision immunotherapy to improve sepsis outcomes: the ImmunoSep randomized clinical trial","volume":"335","author":"Giamarellos-Bourboulis","year":"2026","journal-title":"JAMA"},{"key":"B78","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13054-024-04875-6","article-title":"Vascular leak in sepsis: physiological basis and potential therapeutic advances","volume":"28","author":"McMullan","year":"2024","journal-title":"Crit Care"},{"key":"B79","doi-asserted-by":"publisher","first-page":"R261","DOI":"10.1186\/cc10523","article-title":"The synthetic Tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis","volume":"15","author":"K\u00fcmpers","year":"2011","journal-title":"Crit Care"},{"key":"B80","doi-asserted-by":"publisher","first-page":"335ra55","DOI":"10.1126\/scitranslmed.aad9260","article-title":"Amelioration of sepsis by TIE2 activation-induced vascular protection","volume":"8","author":"Han","year":"2016","journal-title":"Sci Transl Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s00134-021-06537-5","article-title":"Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial","volume":"47","author":"Laterre","year":"2021","journal-title":"Intensive Care Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"10477","DOI":"10.1038\/s41598-024-60919-5","article-title":"Doxycycline protects against sepsis-induced endothelial glycocalyx shedding","volume":"14","author":"De Oliveira","year":"2024","journal-title":"Sci Rep"},{"key":"B83","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/CCM.0000000000003657","article-title":"Effects of mesenchymal stem cell treatment on systemic cytokine levels in a phase 1 dose-escalation safety trial of septic shock patients","volume":"47","author":"Schlosser","year":"2019","journal-title":"Crit Care Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA"},{"key":"B85","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e1000","DOI":"10.1097\/CCE.0000000000001000","article-title":"Corticosteroids in sepsis and septic shock: a systematic review, pairwise, and dose-response meta-analysis","volume":"6","author":"Pitre","year":"2024","journal-title":"Crit Care Explor"},{"key":"B88","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"B89","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","article-title":"Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial","volume":"180","author":"Meisel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nm0697-678","article-title":"Monocyte deactivation in septic patients: restoration by IFN-\u03b3 treatment","volume":"3","author":"D\u00f6cke","year":"1997","journal-title":"Nat Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e98960","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI Insight"},{"key":"B92","doi-asserted-by":"publisher","first-page":"8859","DOI":"10.3390\/ijms26188859","article-title":"Assessing monoclonal and polyclonal antibodies in sepsis and septic shock: a systematic review of efficacy and safety","volume":"26","author":"Goulas","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/jama.2010.158","article-title":"Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial","volume":"303","author":"Jones","year":"2010","journal-title":"JAMA"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1097\/01.CCM.0000132904.35713.A7","article-title":"Early lactate clearance is associated with improved outcome in severe sepsis and septic shock","volume":"32","author":"Nguyen","year":"2004","journal-title":"Crit Care Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13054-016-1421-3","article-title":"Application of a simplified definition of diastolic function in severe sepsis and septic shock","volume":"20","author":"Lanspa","year":"2016","journal-title":"Crit Care"},{"key":"B96","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13089-020-00163-w","article-title":"Quantifying systemic congestion with point-of-care ultrasound: development of the venous excess ultrasound grading system","volume":"12","author":"Beaubien-Souligny","year":"2020","journal-title":"Ultrasound J"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1001\/jama.2015.2316","article-title":"The platform trial: an efficient strategy for evaluating multiple treatments","volume":"313","author":"Berry","year":"2015","journal-title":"JAMA"},{"key":"B98","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1513\/AnnalsATS.202003-192SD","article-title":"The REMAP-CAP randomized embedded multifactorial adaptive platform for community-acquired pneumonia study: rationale and design","volume":"17","author":"Angus","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"B99","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13054-024-05020-z","article-title":"Identification and transcriptomic assessment of latent profile pediatric septic shock phenotypes","volume":"28","author":"Atreya","year":"2024","journal-title":"Crit Care"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1909143\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:06:12Z","timestamp":1790157972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1909143\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":99,"alternative-id":["10.3389\/fmed.2026.1909143"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1909143","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1909143"}}